Status:
RECRUITING
Sleep Apnea in Patients With MGUS and MM
Lead Sponsor:
Michael Tomasson
Collaborating Sponsors:
Department of Health and Human Services
Conditions:
Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance
Eligibility:
All Genders
18-99 years
Brief Summary
This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and without sleep apnea, who are providing bo...
Detailed Description
Obesity is a risk factor for the development of MM, although the mechanisms that link obesity and MM are unclear. Obesity, in turn, is closely associated with obstructive sleep apnea. Interestingly, t...
Eligibility Criteria
Inclusion
- Patients diagnosed with MGUS or MM who will be receiving a bone marrow biopsy as part of their standard of care are eligible to participate in this study
Exclusion
Key Trial Info
Start Date :
May 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 23 2030
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04114084
Start Date
May 23 2019
End Date
May 23 2030
Last Update
November 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242